Predictive genetic testing for type 2 diabetes.
作者信息
Janssens A Cecile J W, Gwinn Marta, Valdez Rodolfo, Narayan K M Venkat, Khoury Muin J
出版信息
BMJ. 2006 Sep 9;333(7567):509-10. doi: 10.1136/bmj.38953.598947.80.
Abstract
摘要
相似文献
1
Predictive genetic testing for type 2 diabetes.2型糖尿病的预测性基因检测
BMJ. 2006 Sep 9;333(7567):509-10. doi: 10.1136/bmj.38953.598947.80.
2
Does genetic testing really improve the prediction of future type 2 diabetes?基因检测真的能改善对未来2型糖尿病的预测吗？
PLoS Med. 2006 Feb;3(2):e114; author reply e127. doi: 10.1371/journal.pmed.0030114. Epub 2006 Feb 28.
3
[Search for type 2 diabetes susceptibility genes].[寻找2型糖尿病易感基因]
Tanpakushitsu Kakusan Koso. 2005 Dec;50(16 Suppl):2084-9.
4
[Important diabetes gene detected].[检测到重要糖尿病基因]
Versicherungsmedizin. 2006 Jun 1;58(2):94.
5
Testing the gene or testing a variant? The case of TCF7L2.检测基因还是检测变异体？以TCF7L2为例。
Diabetes. 2007 Oct;56(10):2417-9. doi: 10.2337/db07-0923.
6
Transcription factor 7-like 2 (TCFL2) - a novel factor involved in pathogenesis of type 2 diabetes. Comment on: Grant et al., Nature Genetics 2006, Published online 15 January 2006.转录因子7样2（TCFL2）——一种参与2型糖尿病发病机制的新因子。评论：格兰特等人，《自然遗传学》2006年，2006年1月15日在线发表。
Horm Metab Res. 2006 Feb;38(2):137-8. doi: 10.1055/s-2006-925137.
7
[Calpain 10 as a susceptibility gene of type 2 diabetes].钙蛋白酶10作为2型糖尿病的易感基因
Nihon Rinsho. 2002 Jul;60 Suppl 7:489-97.
8
[Genetic testing and gene-based testing for type 2 diabetes].[2型糖尿病的基因检测与基于基因的检测]
Nihon Rinsho. 2005 Dec;63 Suppl 12:295-300.
9
A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico.对墨西哥两个不同人群中与2型糖尿病相关的IRS1、CAPN10、TCF7L2和PPARG基因多态性的重复研究。
Ann Hum Genet. 2011 Sep;75(5):612-20. doi: 10.1111/j.1469-1809.2011.00668.x.
10
[Genetics of type 2 diabetes].[2型糖尿病的遗传学]
Internist (Berl). 2005 Jul;46(7):741-2, 744-6, 748-9. doi: 10.1007/s00108-005-1434-5.
引用本文的文献
1
Common genomic variation in the FER gene: useful to stratify patients with sepsis due to pneumonia?FER基因中的常见基因组变异：对因肺炎导致的脓毒症患者进行分层有用吗？
Intensive Care Med. 2015 Jul;41(7):1379-81. doi: 10.1007/s00134-015-3829-7. Epub 2015 Apr 29.
2
Communicating results in post-Belmont era biomonitoring studies: lessons from genetics and neuroimaging research.在贝尔蒙报告之后的生物监测研究中传达结果：来自遗传学和神经影像学研究的经验教训。
Environ Res. 2015 Jan;136:363-72. doi: 10.1016/j.envres.2014.10.001. Epub 2014 Nov 25.
3
Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review.基于已建立的全基因组关联标记物，利用遗传风险模型预测 2 型糖尿病风险：系统评价。
Am J Epidemiol. 2013 Oct 15;178(8):1197-207. doi: 10.1093/aje/kwt123. Epub 2013 Sep 5.
4
Evaluating genomic tests from bench to bedside: a practical framework.从实验室到临床评估基因组检测：一个实用框架。
BMC Med Inform Decis Mak. 2012 Oct 19;12:117. doi: 10.1186/1472-6947-12-117.
5
Multilevel research and the challenges of implementing genomic medicine.多层次研究与实施基因组医学的挑战。
J Natl Cancer Inst Monogr. 2012 May;2012(44):112-20. doi: 10.1093/jncimonographs/lgs003.
6
The role of disease characteristics in the ethical debate on personal genome testing.疾病特征在个人基因组检测伦理争论中的作用。
BMC Med Genomics. 2012 Jan 19;5:4. doi: 10.1186/1755-8794-5-4.
7
Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.个人基因组检测：测试特征以澄清有关伦理、法律和社会问题的论述。
BMC Med Ethics. 2011 Jun 14;12:11. doi: 10.1186/1472-6939-12-11.
8
Improved risk prediction for Crohn's disease with a multi-locus approach.多基因位点方法可改善克罗恩病风险预测。
Hum Mol Genet. 2011 Jun 15;20(12):2435-42. doi: 10.1093/hmg/ddr116. Epub 2011 Mar 22.
9
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.公共卫生框架下的基因检测与常见疾病：如何评估相关性及可能性。欧洲人类遗传学学会关于基因检测与常见疾病建议的背景文件
Eur J Hum Genet. 2011 Apr;19 Suppl 1(Suppl 1):S6-44. doi: 10.1038/ejhg.2010.249.
10
Informed decision making about predictive DNA tests: arguments for more public visibility of personal deliberations about the good life.关于预测性DNA检测的明智决策：支持让个人对美好生活的思考更具公众可见性的论据。
Med Health Care Philos. 2010 May;13(2):127-38. doi: 10.1007/s11019-009-9227-6.
本文引用的文献
1
Genetic prediction of future type 2 diabetes.未来2型糖尿病的遗传预测
PLoS Med. 2005 Nov 1;2(12):e345. doi: 10.1371/journal.pmed.0020345.
2
Does genetic testing really improve the prediction of future type 2 diabetes?基因检测真的能改善对未来2型糖尿病的预测吗？
PLoS Med. 2006 Feb;3(2):e114; author reply e127. doi: 10.1371/journal.pmed.0030114. Epub 2006 Feb 28.
3
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.转录因子7样蛋白2（TCF7L2）基因变体赋予2型糖尿病风险。
Nat Genet. 2006 Mar;38(3):320-3. doi: 10.1038/ng1732. Epub 2006 Jan 15.
4
Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research.自我调节与对DNA风险信息的行为反应：一项理论分析及未来研究框架
Soc Sci Med. 2006 Mar;62(6):1360-8. doi: 10.1016/j.socscimed.2005.08.005. Epub 2005 Sep 12.
5
Diabetes translation research: where are we and where do we want to be?糖尿病翻译研究：我们现在何处，又想去何方？
Ann Intern Med. 2004 Jun 1;140(11):958-63. doi: 10.7326/0003-4819-140-11-200406010-00037.
6
Lifetime risk for diabetes mellitus in the United States.美国糖尿病的终生风险。
JAMA. 2003 Oct 8;290(14):1884-90. doi: 10.1001/jama.290.14.1884.
Zotero 插件